KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Total Non-Current Liabilities (2016 - 2025)

Encompass Health (EHC) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $4.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 23.8% year-over-year to $4.5 billion, compared with a TTM value of $4.5 billion through Dec 2025, up 23.8%, and an annual FY2025 reading of $4.5 billion, up 23.8% over the prior year.
  • Total Non-Current Liabilities was $4.5 billion for Q4 2025 at Encompass Health, up from $3.6 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $4.5 billion in Q4 2025 and bottomed at $3.6 billion in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $4.0 billion, with a median of $4.1 billion recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities surged 2191950.0% in 2021, then dropped 16.02% in 2022.
  • Year by year, Total Non-Current Liabilities stood at $4.4 billion in 2021, then fell by 16.02% to $3.7 billion in 2022, then rose by 2.1% to $3.8 billion in 2023, then decreased by 3.34% to $3.6 billion in 2024, then rose by 23.8% to $4.5 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for EHC at $4.5 billion in Q4 2025, $3.6 billion in Q4 2024, and $3.7 billion in Q2 2024.